NCT04339387View on ClinicalTrials.gov

COVID-19 Risk Stratification

CompletedOBSERVATIONAL
Enrollment

1,326

Participants

Timeline

Start Date

March 1, 2020

Primary Completion Date

April 26, 2020

Study Completion Date

April 26, 2020

Conditions
CoronavirusCoronavirus Sars-Associated as Cause of Disease Classified Elsewhere
Trial Locations (1)

02115

Brigham and Women's Hospital, Boston

All Listed Sponsors
lead

Brigham and Women's Hospital

OTHER

NCT04339387 - COVID-19 Risk Stratification | Biotech Hunter | Biotech Hunter